LinkedIn YouTube Bluesky
Search
EN / FR
Ethics Portal
  • Who We Are
      • Who We Are
      • About Us
      • Business Model
      • Our Strategy 2023-2025
      • Statutes, By-Laws & Policies
      • Governance & Team
      • Annual Reports
      • Careers & RFPs
  • What We Do
      • What We Do
      • Licensing for Public Health
      • mRNA Technology Transfer Programme
      • Disease Areas
      • Addressing Children’s Needs
      • Prioritising Medicines for Licensing
      • Long-Acting Therapeutics
      • Focus areas
      • Biotherapeutics
      • Local and Regional Manufacturing
      • Pandemic Preparedness and Response
      • Upstream Access
      • Technology Transfer
      • Patent Information Tools
      • MedsPaL
      • LAPaL
  • Progress
      • Progress
      • Licences
      • Prioritisation
      • Agreements with Innovators
      • Access to Medicines Tracker
      • Contribution to Universal Health Coverage
      • Endorsements
      • Impact
  • News & Publications
      • News
        & Publications
      • News, Events & Press Releases
      • Messages from the Executive Director
      • MPP in the Media
      • MPP Publications
      • Related Publications
      • Newsletters & Updates
  • Partners
      • Partners
      • Partnering with MPP
      • Funders
      • Our Stories
      • Voices from Friends of MPP
      • Voices from the Frontline
      • I am part of the DTG story
      • How to Give or Get a Licence
  • Contact Us
EN / FR
Ethics Portal
Search
Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network

Latest MPP Publications

Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network

The peer-reviewed article “Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network”, published in The Lancet Child & Adolescent Health, reflects on the experience and lessons from GAP-f’s phase 2 strategy between 2022 and 2024, and how these can inform the work moving forward into GAP-f’s phase 3 […]

30 April 2025

Keyword

Selected Filters:

Loading...
Load More
MPP Logo
  • About Us
  • MedsPaL
  • licences
  • Careers & RFPs
  • Privacy Policy
Follow us
LinkedIn YouTube Bluesky

Founded & funded by

Unitaid Logo

Other funders

Designed and built by ACW